window.factorConfig = {
  Anxiety: {
    type: "range",
    description: "Low score low anxiety.",
    info: `Test name: Anxious mood (MDS UPDRS Part-1). Score range: 0 to 4. Low score means low anxiety. Anxiety is a normal response to stress, but it can become a symptom of an anxiety disorder when it interferes with daily life. Anxiety disorders are treatable, and early intervention can improve long-term outcomes. Anxiety is a common symptom in Parkinson's disease, which can occur years before motor symptoms appear. Chronic anxiety can exacerbate the cognitive and motor symptoms of Parkinson's disease, so it is important to manage anxiety effectively.`,
    img: "https://static.vecteezy.com/system/resources/previews/000/364/335/original/women-with-anxiety-disorder-vector.jpg",
    label: "Score of Anxiety",
    min: 0,
    max: 4,
    value: 1,
  },
  Apathy: {
    type: "range",
    info: `Test name: Apathy (MDS UPDRS Part-1). Score range: 0 to 4. Low score means low apathy. Apathy is a state of indifference or lack of interest in one's surroundings or activities. It can be a symptom of various mental health conditions, such as depression and anxiety. Apathy can also be a response to stress or a coping mechanism for dealing with overwhelming emotions. Apathy is a common symptom in neurodegenerative diseases such as Parkinson's disease. It is characterized by a lack of motivation and decreased interest in daily activities. Studies have suggested that apathy in Parkinson's disease may be caused by changes in the brain's reward and motivation systems.`,
    img: "https://www.calmsage.com/wp-content/uploads/2021/01/Apathy-signs-causes-and-treatment-1.jpg",
    label: "Score of Apathy",
    min: 0,
    max: 4,
    value: 1,
  },
  Benton: {
    type: "range",
    info: `Test name: The Benton Judgment of Line Orientation. Score range: 0 to 20 (derived score is used). High score means more healthy. Purpose: It (JLO) is a test used to assess visual perception and spatial orientation ability. Test format The test consists of 30 cards, each with two sets of 11 lines at different angles. The task is to identify which two lines on each card are oriented in the same direction. Scoring: The test is scored by counting the number of correct responses out of a total of 30, with a maximum score of 30. Norms The Benton JLO has established norms for various populations, including healthy adults, children, and individuals with neurological disorders. Clinical utility: The test is widely used in clinical settings to assess visual perceptual abilities and spatial orientation in patients with brain damage or neurological disorders. Limitations: The test has some limitations, including the fact that it is highly dependent on visual acuity and may not be suitable for individuals with significant visual impairments. Additionally, the test is focused on one specific aspect of visual perception and does not provide a comprehensive assessment of cognitive function.`,
    img: "https://www.mindsware.nl/wp-content/uploads/2018/06/JLO.jpg",
    label: "Score of Benton",
    min: 0,
    max: 20,
    value: 15,
    step: 0.1,
  },
  Clock: {
    type: "range",
    info: `Test name: The clock drawing test. Score range: 0 to 10. High score means more healthy. It is a screening tool used to assess cognitive function, particularly visuospatial and executive abilities. The test involves asking the participant to draw a clock face with numbers and set the hands to a specific time. The test administrator will then evaluate the quality of the drawing and the accuracy of the time placement. The clock drawing test can provide information on a range of cognitive abilities, including attention, memory, planning, organization, and problem-solving. The clock drawing test is relatively quick and easy to administer. Research suggests that the clock drawing test has good sensitivity and specificity for identifying cognitive impairment and dementia. It can be used in combination with other assessment tools to help diagnose and monitor the progression of these conditions. However, the clock drawing test should not be used in isolation to diagnose cognitive impairment or dementia.`,
    img: "https://tdra.utoronto.ca/sites/default/files/styles/square_1_1_600/public/assets/images/clock_result_examples_1.png?itok=bYQZdGn7",
    label: "Score of Clock",
    min: 0,
    max: 10,
    value: 8,
  },
  Cognition: {
    type: "range",
    label: "Score of Cognition",
    info: `Test name: Cognitive impairment (MDS UPDRS Part-1). Score range: 0 to 4. Low score means no impairment. Cognition is the mental process of acquiring, processing, and using information. It can be affected by genetics, environment, and experience. Parkinson's disease can impact cognition. Up to 80% of people with Parkinson's disease experience some degree of cognitive impairment. Cognitive deficits in Parkinson's disease typically involve executive functions such as planning, attention, working memory, and mental flexibility. Treatment for cognitive deficits in Parkinson's disease may involve medication management, cognitive rehabilitation, and lifestyle interventions. Early detection and intervention are crucial for optimizing cognitive function in people with Parkinson's disease.`,
    img: "https://library.neura.edu.au/wp-content/uploads/sites/3/2013/08/Cognition-cropped.jpg",

    min: 0,
    max: 4,
    value: 0,
  },
  COGSTATE: {
    type: "range",
    info: `Test name: Cognitive state. Score range: 0 to 4. Low score means more healthy. Cogstate is a digital cognitive assessment tool that measures cognitive function, including memory, attention, and processing speed. It was founded in 1999 in Melbourne, Australia, by psychologists Brad and Keith Hill. Cogstate assessments are administered on a computer or mobile device and typically take 10-15 minutes to complete. The tests are designed to be engaging and simple to use, with minimal language requirements. Cogstate assessments are widely used in sports medicine to assess athletes who have experienced concussion or other head injuries. They are also used in clinical trials to evaluate the cognitive effects of drugs and other interventions.`,
    img: "https://i1.sndcdn.com/artworks-000533107602-3vprus-t500x500.jpg",
    label: "Score of COGSTATE",
    min: 1,
    max: 3,
    value: 1,
    step: 1,
  },
  Constipate: {
    type: "range",
    info: `Test name: Constipation problems (MDS UPDRS Part-1). Score range: 0 to 4. Low score means no constipation. Constipation is a digestive problem characterized by difficulty passing stools. It can be caused by factors like a lack of fiber in the diet, dehydration, medications, and medical conditions. Treatment may include diet changes, medication, or surgery. Constipation is a common non-motor symptom of Parkinson's disease, affecting many patients. It can occur before motor symptoms. The exact relationship between constipation and Parkinson's disease is not fully understood, but both conditions may share an underlying pathology in the nervous system. Research suggests that constipation may even be a risk factor for developing Parkinson's disease. One study found that chronic constipation increased the risk of Parkinson's disease, but more research is needed to confirm this association.`,
    img: "https://media.istockphoto.com/id/1264103898/vector/vector-illustration-of-intestines-with-hard-dry-feces.jpg?s=612x612&w=0&k=20&c=-5NOQQv4ZX8ILzXOfdl9ZSupJP3lC_N-Xr9Ggv5xNY0=",
    label: "Score of Constipate",
    min: 0,
    max: 4,
    value: 1,
  },
  Depress: {
    type: "range",
    info: `Test name: Depressed mood (MDS UPDRS Part-1). Score range: 0 to 4. Low score means no depression. Depression is a mental health condition that affects people of all ages. It is characterized by feelings of sadness, hopelessness, and loss of interest in activities. Genetic, environmental, and psychological factors can contribute to depression. Stressful life events like trauma or loss can trigger it. Treatment involves therapy and medication. Cognitive-behavioral therapy (CBT) helps change negative thought patterns. Depression is common in Parkinson's disease, affecting up to 50% of patients. Its exact relationship with the disease is not fully understood. Degeneration of dopamine-producing neurons in the brain may contribute to depression in Parkinson's. Treating depression in Parkinson's is challenging due to the potential worsening of motor symptoms by antidepressants. Selective serotonin reuptake inhibitors (SSRIs) may be beneficial for depression and anxiety. Psychotherapy and exercise can also help.`,
    img: "https://pix4free.org/assets/library/2021-10-13/originals/depression.jpg",
    label: "Score of Depress",
    min: 0,
    max: 4,
    value: 1,
  },
  DopaDefic: {
    type: "range",
    info: `Test name: Dopamine dysregulation syndrome (MDS UPDRS Part-1). Score range: 0 to 4. Low score means no symptoms. It considers involvement in a variety of activities including atypical or excessive gambling (e.g. casinos or lottery tickets), atypical or excessive sexual drive or interests (e.g., unusual interest in pornography, masturbation, sexual demands on partner), other repetitive activities (e.g. hobbies, dismantling objects, sorting or organizing), or taking extra non-prescribed medication for non-physical reasons (i.e., addictive behavior).`,
    img: "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcROFCDxK0uMMi_V-6dANg8QJ6EAqRK5RxY7Mg&usqp=CAU",
    label: "Score of DopaDefic",
    min: 0,
    max: 4,
    value: 1,
  },
  Education: {
    type: "range",
    info: `Test name: Years of education. Score range: 5 to 30. Low score means less number of years studied. Education may protect against neurodegenerative diseases like Alzheimer's and Parkinson's. Higher education levels delay disease onset and reduce symptom severity. Studies show that education enhances cognitive reserve, enabling the brain to function despite damage. Thus, educated individuals can compensate for neurodegenerative changes. Educational interventions support cognitive function and quality of life for those with these diseases. These interventions involve memory training, cognitive stimulation, and social support. Learning and mentally engaging activities can slow disease progression and enhance well-being.`,
    img: "https://pix4free.org/assets/library/2021-05-25/originals/education.jpg",
    label: "Score of Education",
    min: 5,
    max: 30,
    value: 15,
  },
  Epworth: {
    type: "range",
    info: `Test name: The Epworth Sleepiness Scale. Score range: 0 to 24. Low score means no symptoms. The ESS is a questionnaire used to assess sleepiness and sleep apnea severity. It consists of eight questions that gauge the likelihood of falling asleep in different situations. Each question is scored from 0 to 3, with 0 meaning no dozing off and 3 meaning almost always dozing off. The total score ranges from 0 to 24, with higher scores indicating more daytime sleepiness. A score of 10 or higher suggests excessive sleepiness. The ESS is validated and reliable in various populations and is used to screen for sleep apnea. It can also monitor treatment effectiveness by tracking changes in sleepiness scores.`,
    img: "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTGBnehOzCo7jcnVvoqPpx7Z0ACz2exRx7eWg&usqp=CAU",
    label: "Score of Epworth",
    min: 0,
    max: 24,
    value: 5,
  },
  Fatigue: {
    type: "range",
    info: `Test name: Fatigue (MDS UPDRS Part-1). Score range: 0 to 4. Low score means no fatigue. Fatigue refers to feeling tired or exhausted due to various reasons like lack of sleep, physical exertion, or illness. It can significantly affect one's quality of life, including concentration, productivity, and emotional well-being. Managing fatigue involves identifying and addressing causes, adopting healthy habits like exercise, a balanced diet, and good sleep. Fatigue is common in Parkinson's disease, affecting up to 50% of patients. It can be caused by the disease itself and the medications used for treatment. Fatigue in Parkinson's and other neurodegenerative diseases can reduce daily activities, quality of life, and impact other symptoms like depression and cognitive impairment.`,
    img: "https://i.pinimg.com/originals/9f/31/7e/9f317e13c588bd9ec1476ca2a9d39f8d.jpg",
    label: "Score of Fatigue",
    min: 0,
    max: 4,
    value: 2,
  },
  Geriatric_Depression: {
    type: "range",
    info: `Test name: The Geriatric Depression Test (short). Score range: 0 to 15. Low score means no depression. The Geriatric Depression Test (GDT) is a self-report questionnaire designed to identify symptoms of depression in adults aged 65 and over. It is a screening tool, not a diagnostic test. A high score on the GDT suggests the presence of depression, but a diagnosis of depression must be made by a healthcare professional. It is easy to administer and can be completed in 10-15 minutes. It can be administered in person, over the phone, or through self-administration. It is available in several different versions, including a short form with 15 questions and a yes/no response format. The GDT has been translated into many different languages and has been used in diverse cultural settings. However, some caution should be exercised when interpreting scores from individuals with limited literacy or cognitive impairment.`,
    img: "https://www.beyondblue.org.au/images/default-source/3.the-facts/meta-data-images/causes-of-depression.png?sfvrsn=603ed2d9_0",
    label: "Score of Geriatric_Depression",
    min: 0,
    max: 15,
    value: 2,
  },
  Hallucination: {
    type: "range",
    info: `Test name: Hallucinations and psychosis (MDS UPDRS Part-1). Score range: 0 to 4. Low score means no hallucinations. Hallucinations are more common in people with Parkinson's disease than in the general population. Visual hallucinations are the most common type of hallucination in Parkinson's disease. Hallucinations can be frightening and disruptive, but they are usually not harmful. Treatment for hallucinations in Parkinson's disease typically involves medication.
`,
    img: "https://media.istockphoto.com/id/1244793784/vector/sleepless-man-and-woman-suffers-from-insomnia.jpg?s=612x612&w=0&k=20&c=EpTC_P3QapNH0OLpDHCXRH72D-Yn1khMnUghVQHAqrc=",
    label: "Score of Hallucination",
    min: 0,
    max: 4,
    value: 0,
    step: 1,
  },
  Hand: {
    type: "range",
    info: `Test name: Hand preference. Score range: 1 to 3. 1 means right, 2 means left and 3 means ambidextrous. Around 90% of people are right-handed, while around 10% are left-handed. The remaining 1% of the population is ambidextrous. Studies have shown that left-handed people tend to have better spatial awareness and are more likely to excel in fields such as mathematics, architecture, and art. Right-handed people are more likely to have better verbal abilities and excel in fields such as writing, language, and public speaking. Ambidextrous people have been found to have a higher incidence of certain mental health conditions. The reason why people have a dominant hand is still not fully understood. Studies have found that the preference for using a particular hand can change over time. This suggests that handedness may not be fully determined at birth.`,
    img: "https://online.notredamecollege.edu/wp-content/uploads/2020/02/ndc_article-left-brain_hero.jpg",
    label: "Score of Hand",
    min: 1,
    max: 3,
    value: 1,
  },
  Hopkins: {
    type: "range",
    info: `Test name: The Hopkins Verbal Learning Test. Score range: 20 to 64 (derived score). High score means more healthy. Purpose: The HVLT is used to assess a person's ability to learn and recall verbal information. Administration: The HVLT consists of three learning trials in which the person is presented with a list of 12 words and asked to recall as many words as possible immediately after each trial. After a 20-30 minute delay, the person is asked to recall the words again (delayed recall). Scoring: The HVLT produces several scores, including total immediate recall, delayed recall, and recognition discriminability. Norms: The HVLT has been standardized on a large sample of individuals, so scores can be compared to the norms for that person's age, education level, and other demographic factors. Advantages: The HVLT is a quick and easy assessment tool that can provide valuable information about a person's verbal learning and memory abilities. Limitations: The HVLT is a useful tool, but it is important to remember that it measures only one aspect of cognitive functioning (verbal learning and memory). It is also not a diagnostic tool on its own, but rather one part of a comprehensive neuropsychological evaluation. Overall, the Hopkins Verbal Learning Test is a valuable tool for assessing verbal learning and memory abilities, and can provide important information for diagnosing and treating cognitive disorders.`,
    img: "https://stoeltingco.com/Products%20Import/Psychological-Testing/image-thumb__1182__Stoelting_gallery_main/32657.webp",
    label: "Score of Hopkins",
    min: 20,
    max: 64,
    value: 55,
  },
  Hopkins_Recog: {
    type: "range",
    info: `Test name: The Hopkins Verbal Learning Test. Score range: 20 to 64 (derived score). High score means more healthy. Purpose: The HVLT is used to assess a person's ability to learn and recall verbal information. Administration: The HVLT consists of three learning trials in which the person is presented with a list of 12 words and asked to recall as many words as possible immediately after each trial. After a 20-30 minute delay, the person is asked to recall the words again (delayed recall). Scoring: The HVLT produces several scores, including total immediate recall, delayed recall, and recognition discriminability. Norms: The HVLT has been standardized on a large sample of individuals, so scores can be compared to the norms for that person's age, education level, and other demographic factors. Advantages: The HVLT is a quick and easy assessment tool that can provide valuable information about a person's verbal learning and memory abilities. Limitations: The HVLT is a useful tool, but it is important to remember that it measures only one aspect of cognitive functioning (verbal learning and memory). It is also not a diagnostic tool on its own, but rather one part of a comprehensive neuropsychological evaluation. Overall, the Hopkins Verbal Learning Test is a valuable tool for assessing verbal learning and memory abilities, and can provide important information for diagnosing and treating cognitive disorders.`,
    img: "https://stoeltingco.com/Products%20Import/Psychological-Testing/image-thumb__1182__Stoelting_gallery_main/32657.webp",
    label: "Score of Hopkins_Recog",
    min: 20,
    max: 61,
    value: 55,
  },
  Impulsive_CompulsiveBehavior: {
    type: "range",
    info: `Test name: The QUIP (Questionnaire for Impulsive-Compulsive Disorders in Parkinson\'s Disease). Score range: 0 to 3. Low score means no symptoms. The QUIP test is a screening tool used to assess impulsive and compulsive behaviors in people with Parkinson's disease. It consists of 19 questions that assess a range of behaviors, including gambling, shopping, eating, and sexual behavior. A positive score on the QUIP test indicates the presence of impulsive or compulsive behaviors and may warrant further evaluation. The QUIP test is a valuable tool for clinicians in assessing the risk of impulsive and compulsive behaviors in people with Parkinson's disease who are being treated with dopamine agonist medications. Impulsive-compulsive behavior is a non-motor symptom that can occur in some people with Parkinson's disease who are being treated with dopamine replacement therapy. These behaviors can include compulsive gambling, excessive shopping, hypersexuality, and binge eating. The exact mechanism behind impulsive-compulsive behavior in Parkinson's disease is not fully understood, but it is thought to be related to the medication's effect on the dopamine system in the brain. Dopamine replacement therapy can lead to changes in the reward pathways of the brain, which may result in impulsive-compulsive behaviors in some people with Parkinson's disease. It is important for healthcare providers to monitor and manage these behaviors, as they can have a significant impact on quality of life and social functioning.`,
    img: "https://news.illinois.edu/files/6367/205112/41022.jpg",
    label: "Score of Impulsive_CompulsiveBehavior",
    min: 0,
    max: 3,
    value: 0,
    step: 0,
  },
  Impulsive_ICD: {
    type: "range",
    info: `Test name: The QUIP (Questionnaire for Impulsive-Compulsive Disorders in Parkinson\'s Disease). Score range: 0 to 8. Low score means no symptoms. The QUIP test is a screening tool used to assess impulsive and compulsive behaviors in people with Parkinson's disease. It consists of 19 questions that assess a range of behaviors, including gambling, shopping, eating, and sexual behavior. A positive score on the QUIP test indicates the presence of impulsive or compulsive behaviors and may warrant further evaluation. The QUIP test is a valuable tool for clinicians in assessing the risk of impulsive and compulsive behaviors in people with Parkinson's disease who are being treated with dopamine agonist medications. Impulsive-compulsive behavior is a non-motor symptom that can occur in some people with Parkinson's disease who are being treated with dopamine replacement therapy. These behaviors can include compulsive gambling, excessive shopping, hypersexuality, and binge eating. The exact mechanism behind impulsive-compulsive behavior in Parkinson's disease is not fully understood, but it is thought to be related to the medication's effect on the dopamine system in the brain. Dopamine replacement therapy can lead to changes in the reward pathways of the brain, which may result in impulsive-compulsive behaviors in some people with Parkinson's disease. It is important for healthcare providers to monitor and manage these behaviors, as they can have a significant impact on quality of life and social functioning.`,
    img: "https://news.illinois.edu/files/6367/205112/41022.jpg",
    label: "Score of Impulsive_ICD",
    min: 0,
    max: 8,
    value: 0,
  },
  LetterNumber: {
    type: "range",
    info: `Test name: Letter Number Sequencing Test. Score range: 4 to 19. High score means more healthy. The LNST is a cognitive assessment tool that measures working memory capacity, attention, and executive functioning. The test involves the presentation of a series of alternating letters and numbers, and the participant is asked to recall them in ascending order according to the letter first and then the number. The test is administered in a standardized manner, with a set number of trials. The difficulty level of the test can be increased or decreased depending on the individual's performance. The LNST is scored based on the number of correct sequences recalled. Scores can be used to assess cognitive function and track changes over time. The LNST has been shown to have good reliability and validity in assessing working memory and executive functioning. It is sensitive to cognitive decline in aging and neurological disorders such as Alzheimer's disease. However, the LNST does not provide a comprehensive assessment of cognitive function. Other tests may be needed to assess additional cognitive domains, such as language, visuospatial ability, and attention.`,
    img: "https://m.media-amazon.com/images/W/WEBP_402378-T1/images/I/81NQiCuTEDL._AC_SL1500_.jpg",
    label: "Score of LetterNumber",
    min: 4,
    max: 19,
    value: 10,
  },
  Lexical_Fluency: {
    type: "range",
    info: `Test name: Lexical Fluency Test. Score range: 10 to 110. High score means more healthy. Lexical fluency is a language assessment tool that measures a person's ability to generate words rapidly and accurately within a specified category. The test typically involves asking the person to name as many words as possible within a specific category within a limited time frame, usually one minute. Lexical fluency is considered a valuable tool for assessing a person's verbal fluency and cognitive flexibility. It can provide insights into language development, cognitive impairment, and certain neurological conditions, such as dementia. The scoring of the test is usually based on the number of correct words generated within the given time frame. While the lexical fluency test is a valuable tool, it is important to recognize that performance on the test can be influenced by factors such as fatigue, anxiety, and cultural background.`,
    img: "https://artofverbalwar.com/wp-content/uploads/2019/08/Copy-of-verbal-fluency.jpg",
    label: "Score of Lexical_Fluency",
    min: 10,
    max: 110,
    value: 60,
  },
  LightHead: {
    type: "range",
    info: `Test name: Light headedness on standing (MDS UPDRS Part-1). Score range: 0 to 4. Low score means no Lightheadedness. It is a common symptom characterized by a sensation of dizziness, weakness, or faintness. It can be caused by a variety of factors, including low blood pressure, dehydration, anxiety, and medication side effects. Lightheadedness can occur suddenly and may be accompanied by symptoms such as blurred vision, nausea, and sweating. In some cases, it may lead to fainting. Treatment for lightheadedness depends on the underlying cause. Simple measures such as drinking plenty of fluids and getting up slowly from a sitting or lying position can help prevent or alleviate symptoms. In some cases, medication or other medical interventions may be necessary. Lightheadedness is a common symptom of Parkinson's disease and may be caused by medication side effects, autonomic dysfunction, or changes in blood pressure regulation. Treatment for lightheadedness in Parkinson's disease may involve adjusting medication dosages or incorporating physical therapy and balance exercises into the management plan. Close monitoring and communication with a healthcare provider is important to ensure effective management of symptoms.`,
    img: "https://www.regionalneurological.com/wp-content/uploads/2020/01/Regional-Neuro_Vertigo.jpeg",
    label: "Score of LightHead",
    min: 0,
    max: 4,
    value: 0,
  },
  Modif_Boston: {
    type: "range",
    info: `Test name: The Modified Boston Naming Test. Score range: 8 to 60. High score means more healthy. The Modified Boston Naming Test (MBNT) is a standardized language assessment tool that evaluates a person\'s ability to retrieve and produce the names of common objects. The MBNT typically consists of 60 line drawings of objects, and the individual being tested is asked to name each object within a specified time limit. The purpose of the MBNT is to assess language disorders, such as aphasia, and to identify cognitive strengths and weaknesses in individuals who have suffered from neurological damage. The MBNT is administered by a trained professional, such as a speech-language pathologist, and can be completed in approximately 10-15 minutes. Scoring for the MBNT is based on the number of objects named correctly within the time limit. A lower score may indicate a language disorder or impairment. The MBNT is a reliable and valid measure of language ability, and has been extensively researched in both clinical and research settings. However, limitations of the MBNT include potential cultural biases in the object names, and the fact that the test only assesses one aspect of language ability.`,
    img: "https://wiki.uiowa.edu/download/attachments/172365852/Language%20Assessment%20wordle.png?version=2&modificationDate=1485204116087&api=v2&effects=border-simple,blur-border",
    label: "Score of Modif_Boston",
    min: 8,
    max: 60,
    value: 50,
  },
  Montreal_Cognitive: {
    type: "range",
    info: `Test name: The Montreal Cognitive Assessment. Score range: 17 to 30. High score means more healthy. It (MoCA) is a brief screening tool used to assess cognitive function in adults, particularly those with mild cognitive impairment (MCI) or early-stage dementia. MoCA consists of a series of questions that assess various cognitive domains, including attention and concentration, memory, language, visuospatial ability, executive function, and orientation. The MoCA test takes around 10 to 15 minutes to complete and is administered by a healthcare professional or trained examiner. MoCA scores range from 0 to 30, with a score of 26 or above considered normal. However, the scoring may vary depending on the age, education, and cultural background of the individual being tested. MoCA is widely used in clinical practice and research settings to identify and track cognitive impairment over time. It is also used to assess the effectiveness of interventions and treatments for cognitive impairment. The MoCA test is available in over 100 languages, making it a useful tool for assessing cognitive function in diverse populations. However, it is important to note that the test is not a substitute for a comprehensive medical evaluation and should be used in conjunction with other diagnostic tools and assessments.`,
    img: "https://www.verywellhealth.com/thmb/BZgsjhVpkAAoNnk4OOHNCHxJg50=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/alzheimers-and-montreal-cognitive-assessment-moca-98617-5bb7c858c9e77c0051582af1.png",
    label: "Score of Montreal_Cognitive",
    min: 17,
    max: 30,
    value: 28,
  },
  Pain: {
    type: "range",
    info: `Test name: Pain and other sensations (MDS UPDRS Part-1). Score range: 0 to 4. Low score means no pain. Pain is a subjective experience that can be influenced by various factors. It can be classified into acute and chronic pain. Pain is a common symptom of Parkinson's disease and can be due to various factors. Pain management is an important aspect of the overall care of people with Parkinson's disease.`,
    img: "https://i.pinimg.com/550x/35/fe/0d/35fe0d1fb6a6238fefb17433b0e9deba.jpg",
    label: "Score of Pain",
    min: 0,
    max: 4,
    value: 1,
  },
  REM_AwakeDream: {
    type: "range",
    info: `Test name: The REM Sleep Behavior Disorder. Score range: 0 to 1. Low score means no symptoms. Questionnaire asks: do you remember dream after awakening. The REM Sleep Behavior Disorder (RBD) Test is a questionnaire designed to assess the presence and severity of symptoms associated with RBD, a sleep disorder characterized by acting out vivid dreams during REM (Rapid Eye Movement) sleep. RBD is a risk factor for Parkinson disease and may precede the onset of symptoms by many years.`,
    img: "https://www.breathclinic.in/wp-content/uploads/2019/04/4.png",
    label: "Score of REM_AwakeDream",
    min: 0,
    max: 1,
    value: 0,
    step: 1,
  },
  REM_AwakeProblem: {
    type: "range",
    info: `Test name: The REM Sleep Behavior Disorder. Score range: 0 to 2. Low score means no symptoms. Awakening problem: Get awake while sleeping.The REM Sleep Behavior Disorder (RBD) Test is a questionnaire designed to assess the presence and severity of symptoms associated with RBD, a sleep disorder characterized by acting out vivid dreams during REM (Rapid Eye Movement) sleep. RBD is a risk factor for Parkinson disease and may precede the onset of symptoms by many years.`,
    img: "https://www.breathclinic.in/wp-content/uploads/2019/04/4.png",
    label: "Score of REM_AwakeProblem",
    min: 0,
    max: 2,
    value: 0,
  },
  REM_Dream: {
    type: "range",
    info: `Test name: The REM Sleep Behavior Disorder. Score range: 0 to 3. Low score means no symptoms. Dream: vivid, action-packed or aggresive. The REM Sleep Behavior Disorder (RBD) Test is a questionnaire designed to assess the presence and severity of symptoms associated with RBD, a sleep disorder characterized by acting out vivid dreams during REM (Rapid Eye Movement) sleep. RBD is a risk factor for Parkinson disease and may precede the onset of symptoms by many years.`,
    img: "https://www.breathclinic.in/wp-content/uploads/2019/04/4.png",
    label: "Score of REM_Dream",
    min: 0,
    max: 3,
    value: 0,
  },
  REM_Movement: {
    type: "range",
    info: `Test name: The REM Sleep Behavior Disorder. Score range: 0 to 6. Low score means no symptoms. Physical activity during sleep: Whether you kick, punch, or jump out of bed during sleep. The REM Sleep Behavior Disorder (RBD) Test is a questionnaire designed to assess the presence and severity of symptoms associated with RBD, a sleep disorder characterized by acting out vivid dreams during REM (Rapid Eye Movement) sleep. RBD is a risk factor for Parkinson disease and may precede the onset of symptoms by many years.`,
    img: "https://www.breathclinic.in/wp-content/uploads/2019/04/4.png",
    label: "Score of REM_Movement",
    min: 0,
    max: 6,
    value: 0,
  },
  SCOPA_Cardio: {
    type: "range",
    info: `Test name: Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction. Score range: 0 to 6. Low score means no symptoms. Problems associated with cardiovascular. The Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction (SCOPA-AUT) is a questionnaire to assess autonomic dysfunction in people with Parkinson's disease. It consists of 25 questions that cover various aspects of autonomic function, including gastrointestinal, urinary, cardiovascular, and sexual function. The questionnaire is scored on a scale of 0-3, with higher scores indicating greater severity of autonomic dysfunction. The SCOPA-AUT has been shown to be a reliable and valid tool for assessing autonomic dysfunction in people with PD. It can be used to monitor changes in autonomic function over time and to assess the effectiveness of treatments for autonomic dysfunction. In addition to the SCOPA-AUT, there are several other scales and questionnaires that are commonly used to assess outcomes in PD. Overall, the SCOPA-AUT is a useful tool for assessing autonomic dysfunction in people with PD and can help healthcare professionals provide appropriate treatment and support to improve quality of life.`,
    img: "https://www.simplypsychology.org/wp-content/uploads/Autonomic-Nervous-System.jpeg",
    label: "Score of SCOPA_Cardio",
    min: 0,
    max: 6,
    value: 1,
  },
  SCOPA_Eye: {
    type: "range",
    info: `Test name: Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction. Score range: 0 to 3. Low score means no symptoms. Problem associated with eye being sensitive to bright light. The Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction (SCOPA-AUT) is a questionnaire to assess autonomic dysfunction in people with Parkinson's disease. It consists of 25 questions that cover various aspects of autonomic function, including gastrointestinal, urinary, cardiovascular, and sexual function. The questionnaire is scored on a scale of 0-3, with higher scores indicating greater severity of autonomic dysfunction. The SCOPA-AUT has been shown to be a reliable and valid tool for assessing autonomic dysfunction in people with PD. It can be used to monitor changes in autonomic function over time and to assess the effectiveness of treatments for autonomic dysfunction. In addition to the SCOPA-AUT, there are several other scales and questionnaires that are commonly used to assess outcomes in PD. Overall, the SCOPA-AUT is a useful tool for assessing autonomic dysfunction in people with PD and can help healthcare professionals provide appropriate treatment and support to improve quality of life.`,
    img: "https://www.simplypsychology.org/wp-content/uploads/Autonomic-Nervous-System.jpeg",
    label: "Score of SCOPA_Eye",
    min: 0,
    max: 3,
    value: 1,
  },
  SCOPA_Gastro: {
    type: "range",
    info: `Test name: Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction. Score range: 0 to 9. Low score means no symptoms. Problems associated with constipation. The Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction (SCOPA-AUT) is a questionnaire to assess autonomic dysfunction in people with Parkinson's disease. It consists of 25 questions that cover various aspects of autonomic function, including gastrointestinal, urinary, cardiovascular, and sexual function. The questionnaire is scored on a scale of 0-3, with higher scores indicating greater severity of autonomic dysfunction. The SCOPA-AUT has been shown to be a reliable and valid tool for assessing autonomic dysfunction in people with PD. It can be used to monitor changes in autonomic function over time and to assess the effectiveness of treatments for autonomic dysfunction. In addition to the SCOPA-AUT, there are several other scales and questionnaires that are commonly used to assess outcomes in PD. Overall, the SCOPA-AUT is a useful tool for assessing autonomic dysfunction in people with PD and can help healthcare professionals provide appropriate treatment and support to improve quality of life.`,
    img: "https://www.simplypsychology.org/wp-content/uploads/Autonomic-Nervous-System.jpeg",
    label: "Score of SCOPA_Gastro",
    min: 0,
    max: 9,
    value: 1,
  },
  SCOPA_Sex: {
    type: "range",
    info: `Test name: Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction. Score range: 0 to 6. Low score means no symptoms. Sexual life related rpoblems. The Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction (SCOPA-AUT) is a questionnaire to assess autonomic dysfunction in people with Parkinson's disease. It consists of 25 questions that cover various aspects of autonomic function, including gastrointestinal, urinary, cardiovascular, and sexual function. The questionnaire is scored on a scale of 0-3, with higher scores indicating greater severity of autonomic dysfunction. The SCOPA-AUT has been shown to be a reliable and valid tool for assessing autonomic dysfunction in people with PD. It can be used to monitor changes in autonomic function over time and to assess the effectiveness of treatments for autonomic dysfunction. In addition to the SCOPA-AUT, there are several other scales and questionnaires that are commonly used to assess outcomes in PD. Overall, the SCOPA-AUT is a useful tool for assessing autonomic dysfunction in people with PD and can help healthcare professionals provide appropriate treatment and support to improve quality of life.`,
    img: "https://www.simplypsychology.org/wp-content/uploads/Autonomic-Nervous-System.jpeg",
    label: "Score of SCOPA_Sex",
    min: 0,
    max: 6,
    value: 1,
  },
  SCOPA_Thermo: {
    type: "range",
    info: `Test name: Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction. Score range: 0 to 6. Low score means no symptoms. Problem tolerating heat, cold, sunlight. The Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction (SCOPA-AUT) is a questionnaire to assess autonomic dysfunction in people with Parkinson's disease. It consists of 25 questions that cover various aspects of autonomic function, including gastrointestinal, urinary, cardiovascular, and sexual function. The questionnaire is scored on a scale of 0-3, with higher scores indicating greater severity of autonomic dysfunction. The SCOPA-AUT has been shown to be a reliable and valid tool for assessing autonomic dysfunction in people with PD. It can be used to monitor changes in autonomic function over time and to assess the effectiveness of treatments for autonomic dysfunction. In addition to the SCOPA-AUT, there are several other scales and questionnaires that are commonly used to assess outcomes in PD. Overall, the SCOPA-AUT is a useful tool for assessing autonomic dysfunction in people with PD and can help healthcare professionals provide appropriate treatment and support to improve quality of life.`,
    img: "https://www.simplypsychology.org/wp-content/uploads/Autonomic-Nervous-System.jpeg",
    label: "Score of SCOPA_Thermo",
    min: 0,
    max: 6,
    value: 1,
  },
  SCOPA_Urine: {
    type: "range",
    info: `Test name: Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction. Score range: 0 to 17. Low score means no symptoms. Problem associted with passing urine. The Scales for Outcomes in Parkinson’s Disease - Autonomic Dysfunction (SCOPA-AUT) is a questionnaire to assess autonomic dysfunction in people with Parkinson's disease. It consists of 25 questions that cover various aspects of autonomic function, including gastrointestinal, urinary, cardiovascular, and sexual function. The questionnaire is scored on a scale of 0-3, with higher scores indicating greater severity of autonomic dysfunction. The SCOPA-AUT has been shown to be a reliable and valid tool for assessing autonomic dysfunction in people with PD. It can be used to monitor changes in autonomic function over time and to assess the effectiveness of treatments for autonomic dysfunction. In addition to the SCOPA-AUT, there are several other scales and questionnaires that are commonly used to assess outcomes in PD. Overall, the SCOPA-AUT is a useful tool for assessing autonomic dysfunction in people with PD and can help healthcare professionals provide appropriate treatment and support to improve quality of life.`,
    img: "https://www.simplypsychology.org/wp-content/uploads/Autonomic-Nervous-System.jpeg",
    label: "Score of SCOPA_Urine",
    min: 0,
    max: 17,
    value: 1,
  },
  Semantic: {
    type: "range",
    info: `Test name: The Semantic Fluency Test. Score range: 25 to 81 (derived score). High score means mre healthy. The Semantic Fluency Test is a widely used cognitive assessment tool that measures an individual\'s ability to generate words or phrases related to a given category. In the test, participants are asked to generate as many words or phrases as possible within a specified time limit, usually one minute, that are related to a specific category, such as animals, fruits, or countries. The Semantic Fluency Test is designed to assess an individual\'s semantic memory, which is the ability to recall and access information about concepts and their relationships. The test is often used in neuropsychological evaluations to detect impairments in semantic memory, which can occur as a result of neurological disorders such as Alzheimer\'s disease or stroke. The test has been shown to be a reliable and valid measure of semantic memory, with good test-retest reliability and sensitivity to cognitive impairments. The Semantic Fluency Test is commonly administered in both verbal and written formats, with participants either speaking their responses or writing them down. The test is often used in conjunction with other cognitive assessments, such as the Mini-Mental State Examination (MMSE), to provide a comprehensive evaluation of an individual\'s cognitive functioning.`,
    img: "https://randomwordgenerator.com/img/random-word-generator.jpg",
    label: "Score of Semantic",
    min: 25,
    max: 81,
    value: 70,
  },
  SleepDay: {
    type: "range",
    info: `Test name: Daytime sleepiness (MDS UPDRS Part-1). Score range: 0 to 4. Low score means no symptoms. Involuntary daytime sleeping, or EDS, is a condition in which a person feels the need to sleep during the day. EDS can be caused by a variety of factors, including sleep disorders, medications, and underlying medical conditions. EDS can have a significant impact on a person's quality of life. Involuntary daytime sleeping is a common symptom of Parkinson's disease, affecting up to 50% of patients. EDS in Parkinson's disease is thought to be caused by changes in the brain's sleep-wake cycle.`,
    img: "https://images.freeimages.com/clg/istock/previews/9431/94319265-businessman-working-day-sleeping-businessman-at-work-office-life.jpg",
    label: "Score of SleepDay",
    min: 0,
    max: 4,
    value: 0,
  },
  SleepNight: {
    type: "range",
    info: `Test name: Sleep problems (MDS UPDRS Part-1). Score range: 0 to 4. Low score means no symptoms. Insomnia, sleep apnea, restless leg syndrome, and RBD are common sleep disorders that can cause difficulty sleeping at night. These disorders can lead to fatigue, irritability, and other health problems. Sleep fragmentation and circadian rhythm disorders are common sleep disturbances among people with neurodegenerative diseases. These disturbances can lead to daytime sleepiness, fatigue, and cognitive impairment. People with neurodegenerative diseases are more likely to experience sleep problems. If you are experiencing sleep problems, talk to your doctor to rule out any underlying medical conditions. There are also treatments available that can help improve your sleep.`,
    img: "https://media.istockphoto.com/id/1244793784/vector/sleepless-man-and-woman-suffers-from-insomnia.jpg?s=612x612&w=0&k=20&c=EpTC_P3QapNH0OLpDHCXRH72D-Yn1khMnUghVQHAqrc=",
    label: "Score of SleepNight",
    min: 0,
    max: 4,
    value: 0,
  },
  STAIA: {
    type: "range",
    info: `Test name: The State-Trait Anxiety Inventory: Trait Anxiety Scale (T-Anxiety). Score range: 20 to 80. Low score means low anxiety. The State-Trait Anxiety Inventory (STAI) is a psychological assessment tool used to measure anxiety levels in individuals. It was developed in the late 1960s by psychologist Charles Spielberger. The STAI test consists of two separate scales: the State Anxiety Scale and the Trait Anxiety Scale. The State Anxiety Scale measures how anxious an individual is feeling at the time of the test, while the Trait Anxiety Scale measures how anxious an individual tends to be in general. The STAI test is considered to be a reliable and valid measure of anxiety, and has been translated into numerous languages for use around the world. Some limitations of the test include the potential for response biases and the fact that it may not be sensitive enough to detect changes in anxiety levels over time. The STAI test is not intended to be used as a diagnostic tool, and should be used in conjunction with other assessment methods to make clinical decisions.`,
    img: "https://media.istockphoto.com/id/1301795370/vector/concept-victim-of-bullying-cyber-harassment-cyberstalking-portrait-of-woman-with-frustration.jpg?s=612x612&w=0&k=20&c=M5P06XWXw1irDGcQ4ISTHf3yDhV6FRNwMYrUMp2S9W4=",
    label: "Score of STAIA",
    min: 20,
    max: 80,
    value: 30,
  },
  STAIS: {
    type: "range",
    info: `Test name: The State-Trait Anxiety Inventory: State Anxiety Scale (S-Anxiety). Score range: 20 to 80. Low score means low anxiety. The State-Trait Anxiety Inventory (STAI) is a psychological assessment tool used to measure anxiety levels in individuals. It was developed in the late 1960s by psychologist Charles Spielberger. The STAI test consists of two separate scales: the State Anxiety Scale and the Trait Anxiety Scale. The State Anxiety Scale measures how anxious an individual is feeling at the time of the test, while the Trait Anxiety Scale measures how anxious an individual tends to be in general. The STAI test is considered to be a reliable and valid measure of anxiety, and has been translated into numerous languages for use around the world. Some limitations of the test include the potential for response biases and the fact that it may not be sensitive enough to detect changes in anxiety levels over time. The STAI test is not intended to be used as a diagnostic tool, and should be used in conjunction with other assessment methods to make clinical decisions.`,
    img: "https://media.istockphoto.com/id/1301795370/vector/concept-victim-of-bullying-cyber-harassment-cyberstalking-portrait-of-woman-with-frustration.jpg?s=612x612&w=0&k=20&c=M5P06XWXw1irDGcQ4ISTHf3yDhV6FRNwMYrUMp2S9W4=",
    label: "Score of STAIS",
    min: 20,
    max: 80,
    value: 30,
  },
  Symbol_Digit: {
    type: "range",
    info: `Test name: The Symbol Digit Modalities Test. Score range: 20 to 80. High score means more healthy. The Symbol Digit Modalities Test (SDMT) is a neuropsychological assessment tool that measures cognitive processing speed and attention. The SDMT requires the test-taker to match specific symbols with their corresponding numbers as quickly as possible within a set time limit. The test is widely used in clinical and research settings to evaluate cognitive impairments in various neurological conditions, such as multiple sclerosis, traumatic brain injury, and Alzheimer\'s disease. The SDMT is a relatively simple test to administer and takes around 5-10 minutes to complete, making it a practical choice for busy clinical environments. The test is sensitive to changes in cognitive function over time, which can be useful for monitoring disease progression or the effectiveness of treatment. There are several versions of the SDMT available, each with different symbol sets and scoring methods, but they all assess cognitive processing speed and attention using the same basic principles.`,
    img: "https://www.mindsware.nl/wp-content/uploads/2018/06/SDMT-1.jpg",
    label: "Score of Symbol_Digit",
    min: 20,
    max: 80,
    value: 60,
  },
  Trail_Making_A: {
    type: "range",
    info: `Test name: The Trail Making Test. Score range: 1 to 150. Low score means more healthy. The Trail Making Test (TMT) is a neuropsychological assessment tool that evaluates visual attention, processing speed, and executive function. Part A of the TMT requires the individual to connect a series of 25 encircled numbers as quickly as possible. This task assesses visual scanning ability, attention, and processing speed. A shorter time indicates better performance, as it suggests faster cognitive processing speed and visual-motor skills. The TMT is a valuable tool for assessing cognitive function and identifying impairments in visual attention, processing speed, and executive function. The test can be used in a variety of settings and has been shown to have good reliability and validity.`,
    img: "https://www.researchgate.net/profile/Jae-Won-Jang-4/publication/305036435/figure/fig1/AS:381578460057600@1467986802026/Three-versions-of-Trail-Making-Test-Practice-tests-of-original-TMT-a-TMT-Korean.png",
    label: "Score of Trail_Making_A",
    min: 1,
    max: 150,
    value: 30,
  },
  Trail_Making_B: {
    type: "range",
    info: `Test name: The Trail Making Test. Score range: 1 to 294. Low score means more healthy. The Trail Making Test (TMT) is a neuropsychological assessment tool that evaluates visual attention, processing speed, and executive function. Part B of the TMT is a more complex version of the test that requires the individual to connect a series of 25 encircled numbers and letters in an alternating pattern. This task assesses cognitive flexibility, working memory, and mental processing speed. A shorter time suggests better cognitive flexibility, attention, and executive functioning. The TMT is a valuable tool for assessing cognitive function and identifying impairments in visual attention, processing speed, and executive function. The test can be used in a variety of settings and has been shown to have good reliability and validity.`,
    img: "https://www.researchgate.net/profile/Jae-Won-Jang-4/publication/305036435/figure/fig1/AS:381578460057600@1467986802026/Three-versions-of-Trail-Making-Test-Practice-tests-of-original-TMT-a-TMT-Korean.png",
    label: "Score of Trail_Making_B",
    min: 1,
    max: 294,
    value: 70,
  },
  UPSIT: {
    type: "range",
    info: `Test name: The UPSIT test (University of Pennsylvania Smell Identification Test). Score range: 0 to 40. High score means no smell dysfunction. The UPSIT test is a standardized smell identification test that evaluates a person's ability to identify odors. It consists of 40 scratch-and-sniff cards with different scents, ranging from common ones like coffee to more obscure ones like turpentine. Scores range from 0 to 40, higher scores indicating better olfactory function. UPSIT is used to diagnose olfactory dysfunction, a symptom of neurological disorders like Alzheimer's and Parkinson's. It's a quick and non-invasive tool for healthcare professionals to assess smell and monitor certain conditions. Olfactory dysfunction is a common non-motor symptom of Parkinson's, with up to 90% of patients experiencing some degree of smell loss. This symptom may precede other motor symptoms like tremors or stiffness. The exact link between smell loss and Parkinson's is not fully understood but is thought to involve degeneration of neurons and the accumulation of abnormal protein deposits known as Lewy bodies. Olfactory dysfunction is considered a potential early biomarker for Parkinson's, aiding in early detection and intervention.`,
    img: "https://www.uclahealth.org/sites/default/files/styles/landscape_3x2_016000_640x427/public/images/f6/sense-smell-image-istock-1302713332.jpg?f=e0a38ea0&itok=bdHAIIgu",
    label: "Score of UPSIT",
    min: 0,
    max: 40,
    value: 36,
  },
  Urine: {
    type: "range",
    info: `Test name: Urinary problems (MDS UPDRS Part-1). Score range: 0 to 4. Low score means no symptoms. Urinary Tract Infections (UTIs): UTIs are common urinary problems that occur due to bacterial infection. Symptoms include pain or burning sensation during urination, frequent urination, and cloudy or foul-smelling urine. Urinary Incontinence: Urinary incontinence is the involuntary leakage of urine. It can occur due to weak bladder muscles, overactive bladder muscles, or nerve damage. Kidney Stones: Kidney stones are hard deposits of minerals and salts that form in the kidneys. They can cause pain in the back or lower abdomen, and difficulty passing urine. Urinary dysfunction is a common non-motor symptom of Parkinson\'s disease. It can include urinary urgency, frequency, and incontinence. Research has shown that changes in urinary biomarkers, such as increased levels of alpha-synuclein, may be associated with the early stages of Parkinson\'s disease. In some neurodegenerative diseases, such as Multiple System Atrophy (MSA), urinary dysfunction is a prominent symptom. MSA is a rare disorder that affects the autonomic nervous system, causing symptoms such as orthostatic hypotension and urinary incontinence.`,
    img: "https://media.istockphoto.com/id/1218610779/vector/an-unhealthy-kidney-mascot-renal-failure.jpg?s=170667a&w=0&k=20&c=zHyL3e40zqEaWzPu0fm0Qt8vstuFjedNLPOF0paipX4=",
    label: "Score of Urine",
    min: 0,
    max: 4,
    value: 0,
  },
};

console.log("factorConfig loaded");
